A Phase I, Open Label, Multiple Dose, Dose Escalation Study OF GW786034 In Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2013
At a glance
- Drugs Pazopanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 19 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2005 New trial record.